SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D10ADF23E5D8D62475E0694A29FECB597D662B9F87C0CEBA46B1A6EA0AAB7C930D4E96E1CCC8467A8E7DC5FFB12BAB61>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D10ADF23E5D8D62475E0694A29FECB597D662B9F87C0CEBA46B1A6EA0AAB7C930D4E96E1CCC8467A8E7DC5FFB12BAB61
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D10ADF23E5D8D62475E0694A29FECB597D662B9F87C0CEBA46B1A6EA0AAB7C930D4E96E1CCC8467A8E7DC5FFB12BAB61
http://www.w3.org/2000/01/rdf-schema#comment
"Serum NSE may be a novel marker of disease aggressiveness as well as a prognostic factor for DLBCL in the era of rituximab."
xsd:string
http://purl.uniprot.org/uniprot/#_EA78D8BECCD2E2C248706F8FBF34EE6B8C531AE5350168E94DE14C2852BCF288E715552C522B57D1CA8305A945269ED9
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D10ADF23E5D8D62475E0694A29FECB597D662B9F87C0CEBA46B1A6EA0AAB7C930D4E96E1CCC8467A8E7DC5FFB12BAB61
http://purl.uniprot.org/uniprot/P09104
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D10ADF23E5D8D62475E0694A29FECB597D662B9F87C0CEBA46B1A6EA0AAB7C930D4E96E1CCC8467A8E7DC5FFB12BAB61
http://purl.uniprot.org/uniprot/#_P09104-mappedCitation-21815777
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D10ADF23E5D8D62475E0694A29FECB597D662B9F87C0CEBA46B1A6EA0AAB7C930D4E96E1CCC8467A8E7DC5FFB12BAB61